NMN supplements from several manufacturers are positioned on an orange background.
RegulatoryThe future of NMN: NPA lawsuit, amended FDA petition might determine itNMN's future depends on NPA lawsuit, amended FDA petition
A lawsuit against the government and amended citizen petition filed with the U.S. Food and Drug Administration by the Natural Products Association could determine the future of β-NMN in dietary supplements, with potentially larger implications for innovation in a $67 billion-a-year industry.
Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.